15th Georg RAJKA ISAD Presentation: Zabalafin Hydrogel – A Novel Topical Botanical Drug That Addresses the Four Demons of Atopic Dermatitis

15th Georg RAJKA International Symposium on Atopic Dermatitis Presentation: Zabalafin Hydrogel – A Novel Topical Botanical Drug That Addresses the Four Demons of Atopic Dermatitis NEWS PROVIDED BY Alphyn Biologics October 27, 2025, 07:30 ET 1168_Neal-KOLLER_phase-2b-trial-of-zabalafin-hydrogel-a-novel-topical-botanical-drug-that-addresses-the-four-demons-of-atopic-dermatitis CONTACTS   Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687   Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195

EADV Congress 2025 Poster Presentation: Zabalafin Hydrogel – A Novel, Safe, and Effective Topical Botanical Drug That Comprehensively Addresses the Four Demons of Atopic Dermatitis

EADV Congress 2025 Poster Presentation: Zabalafin Hydrogel – A Novel, Safe, and Effective Topical Botanical Drug That Comprehensively Addresses the Four Demons of Atopic Dermatitis NEWS PROVIDED BY Alphyn Biologics September 23, 2025, 07:30 ET CONTACTS   Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687   Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195

2025 Integrative Dermatology Summit Poster Presentation: Zabalafin Hydrogel, A Novel Topical Botanical Drug That Addresses The Four Demons of Atopic Dermatitis

2025 Integrative Dermatology Summit Poster Presentation: Zabalafin Hydrogel, A Novel Topical Botanical Drug That Addresses The Four Demons of Atopic Dermatitis NEWS PROVIDED BY Alphyn Biologics August 12, 2025, 07:30 ET CONTACTS   Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687   Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195

50th Annual Society for Pediatric Dermatology Meeting Poster Presentation: Zabalafin Hydrogel, A Novel Topical Botanical Drug That Addresses The Four Demons of Atopic Dermatitis

50th Annual Society for Pediatric Dermatology Meeting Poster Presentation: Zabalafin Hydrogel, A Novel Topical Botanical Drug That Addresses The Four Demons of Atopic Dermatitis NEWS PROVIDED BY Alphyn Biologics July 22, 2025, 07:30 ET CONTACTS   Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687   Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195

Alphyn’s Zabalafin Hydrogel for Atopic Dermatitis Highlighted in Leading Peer-Reviewed Journal

Alphyn’s Zabalafin Hydrogel for Atopic Dermatitis Highlighted in Leading Peer-Reviewed Journal NEWS PROVIDED BY Alphyn Biologics Jul 01, 2025, 07:30 ET Expert dermatologist panel creates new atopic dermatitis (AD) algorithm (stepped diagnosis and treatment recommendations) emphasizing need for therapeutics that address AD’s intense itch, inflammation, and the AD disease stages of Staphylococcus aureus (Staph) colonization…